131030.KQ DHP Korea Co. Ltd

Healthcare Pharmaceuticals KOSDAQ
5,810 KRW
Close of Oct 30, 2026
4,610 20,750
Market cap
KRW 101B
P/E
7.4x
P/B
0.56x
ROE
7.1%
Dividend yield
-
Fundamental score
2.1/5

Ratios use the latest price and the current fiscal year annualized from 2 quarters up to Jun 2026.

Is 131030.KQ undervalued?

Graham number
Price5,810
Graham value13,497
Discount57.0%

131030.KQ trades 57.0% below its Graham number.

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

DHP Korea Co. Ltd fundamental analysis

10 of 22 checks passed

ROE 0/2

Low return on equity (7.1%), below 10%.

ROA 1/1

Return on assets (6.5%) is above the industry median (3.4%).

Profit Consistency 2/2

Profitable for 10 consecutive years.

Earnings Growth 5Y 0/1

Earnings per share did not grow over the past 5 years.

Earnings Acceleration 0/1

Last year's EPS growth (-3.1%) is not above the 5-year average (-6.2% a year).

Earnings Growth vs Industry 0/1

Last year's EPS growth (-3.1%) is below the industry median (6.6%).

Revenue Growth 2/2

Revenue grew 14.1% a year over the past 3 years.

Short-term Liquidity 1/1

Current assets cover short-term liabilities.

Long-term Liabilities 1/1

Current assets cover long-term liabilities.

Debt to Equity 0/2

Debt to equity cannot be calculated: debt is not reported or equity is negative.

Debt Trend 0/1

Debt to equity has risen over the past 5 years.

Debt Coverage 0/1

Debt is not reported.

Interest Coverage 1/1

EBIT is 185.1x against interest expense, well covered.

PE vs Market 1/1

PE (7.4x) is below the market median (11.3x).

PE vs Industry 1/1

PE (7.4x) is below the industry median (19.4x).

PBV 1/1

Price to book (0.6x) is below the industry median (0.8x).

Graham Number 1/1

The price is below the Graham number (PE x PB = 4.2, limit 22.5).

PEG 0/1

PEG needs positive PE and positive 5-year earnings growth.

Dividend Yield 0/2

No dividend paid in the last reported year.

Dividend Stability 0/2

Dividends were not paid steadily for the past 5 years.

Dividend Growth 0/1

Dividends paid did not grow over the past 5 years.

Payout Ratio 0/1

No dividend, or no profit to pay it from.

Each check is worth 1 or 2 points by how much it says about the quality of the company. The score is the share of points earned, out of 5. Ask AI to explain this score

DHP Korea Co. Ltd stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About DHP Korea Co. Ltd

OPTUS Pharmaceutical Co., Ltd. provides ophthalmic solutions in South Korea. The company offers dry eye preparation, antibiotics, anti-allergic preparation, steroids preparation, glaucoma treatment, and retinopathy treatment products. It also provides ETC, OTC, cosmetics, healthcare, and other products, as well as single-dose unit eye drops and eye care products under OEU& brand name. The company was formerly known as DHP Korea Co., Ltd. OPTUS Pharmaceutical Co., Ltd. was fo…

Full company profile